News
ATR
121.39
-1.00%
-1.23
How Investors Are Reacting To AptarGroup (ATR) Landing Its First Dual Bidose Cardiovascular Nasal Product
Simply Wall St · 1d ago
AptarGroup (ATR): Assessing Valuation After CARDAMYST Nasal Spray Milestone in Drug Delivery Solutions
Simply Wall St · 2d ago
Aptar's Intranasal Technology to Be Used for Milestone's FDA-Approved Heart Treatment
Dow Jones · 2d ago
AptarGroup Announces That Its Bidose Liquid Nasal Spray System Liquid Is The Mechanism For Delivering The Newly Approved CARDAMYST
Benzinga · 2d ago
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Barchart · 3d ago
AptarGroup’s CAO Makes a Major Move with Stock Sale
TipRanks · 4d ago
Weekly Report: what happened at ATR last week (1208-1212)?
Weekly Report · 5d ago
Did AptarGroup’s (ATR) Legal and Inventory Strains Just Challenge Its Innovation-Led Premium Narrative?
Simply Wall St · 12/11 06:20
General Motors and AptarGroup have been highlighted as Zacks Bull and Bear of the Day
NASDAQ · 12/09 13:28
Bear of the Day: AptarGroup (ATR)
NASDAQ · 12/09 09:00
Weekly Report: what happened at ATR last week (1201-1205)?
Weekly Report · 12/08 09:04
Reassessing AptarGroup (ATR) After a 28% Share Price Slide: Is the Market Overlooking Its Growth?
Simply Wall St · 12/06 14:27
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
Barchart · 12/04 16:00
Is the Options Market Predicting a Spike in AptarGroup Stock?
NASDAQ · 12/03 16:01
Aptar Strengthens Latin America Footprint With Sommaplast Buy
Benzinga · 12/02 18:13
AptarGroup’s Strategic Acquisition of Sommaplast: Hold Rating Amid Fair Valuation
TipRanks · 12/02 12:55
AptarGroup Acquires Sommaplast
Dow Jones · 12/01 22:33
AptarGroup Acquires Brazilian Pharma Packaging Specialist Sommaplast; No Financial Terms Disclosed
Benzinga · 12/01 22:13
*AptarGroup Acquires Sommaplast, a Provider of Oral Dosing Pharma Packaging Products
Dow Jones · 12/01 22:04
Weekly Report: what happened at ATR last week (1124-1128)?
Weekly Report · 12/01 09:04
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.